NeuroXess Announces First Successful Clinical Trial of China's First Fully Implantable, Wireless, and Multifunctional Brain-Computer Interface

On December 13, reporters from The Paper learned that NeuroXess independently developed China’s first and the world’s second fully implanted, fully wireless, and full-featured brain-computer interface product with a built-in battery. It successfully completed its first clinical trial at Huashan Hospital Affiliated with Fudan University. The patient, who had been completely paralyzed below the shoulders for eight years due to a high-level spinal cord injury, was transferred to a general ward one day after the surgery. Five days after the surgery, the device was turned on for the first time, enabling the patient to control the cursor, browse the web, and interact with games through thought.

Interface News learned that the solution implants all core modules (including the battery) entirely within the body, with no cables or interfaces exposed on the skin surface, eliminating the risk of infection commonly associated with traditional external systems at the physical level. In this solution, NeuroXess placed the battery module under the skin near the chest and optimized the mature deep brain stimulation (DBS) technology architecture. During standard testing, the patient’s brain-controlled decoding rate reached 5.2 BPS, comparable to international top-tier levels. This breakthrough marks key progress in safety and system integration for brain-computer interface technology in China.

NeuroXess Founder and Chief Scientist Tao Hu Reveals to Jiemian News: To Date, 54 Brain-Computer Interface Clinical Trials Have Been Conducted Nationwide. Next, the Focus Will Be on Expanding Clinical Research Centers to 10 by 2026, While Accelerating New Product Development and Clinical Demonstrations.